No profile data available.
Allergy Therapeutics plc (AGY.L) is a healthcare company in the allergy treatment pharmaceuticals industry, based in Worthing, United Kingdom, with about 584 full-time employees.
Rest of World was its largest region in fiscal year 2025, with 41% of revenue. Its market capitalization was 300.80 million GBP as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended June 30, 2024; market data as of October 9, 2026.
Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally.
Rest of World: 41% of revenue by region in fiscal year 2025, followed by Germany (31%).
300.80 million GBP as of October 9, 2026.
Listed companies of a similar size in the same industry (allergy treatment pharmaceuticals) include DBV Technologies S.a. (0QAJ.IL).